Claire D. James

1.1k total citations
36 papers, 675 citations indexed

About

Claire D. James is a scholar working on Epidemiology, Oncology and Molecular Biology. According to data from OpenAlex, Claire D. James has authored 36 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 16 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Claire D. James's work include Cervical Cancer and HPV Research (20 papers), Cancer-related Molecular Pathways (10 papers) and Virus-based gene therapy research (5 papers). Claire D. James is often cited by papers focused on Cervical Cancer and HPV Research (20 papers), Cancer-related Molecular Pathways (10 papers) and Virus-based gene therapy research (5 papers). Claire D. James collaborates with scholars based in United States, United Kingdom and Finland. Claire D. James's co-authors include Iain M. Morgan, Molly L. Bristol, Sally Roberts, Xu Wang, Dipon Das, Michael R. Evans, Tara J. Nulton, Craig Delury, Gillian Knight and Elizabeth K. Marsh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Journal of Virology.

In The Last Decade

Claire D. James

36 papers receiving 669 citations

Peers

Claire D. James

EPIDE

ONCOL

GENET

IMMUN

Kavi P.M. Mehta United States

Felicitas Bossler Germany

Anna Jackman Israel

Nienke Kettelarij Netherlands

Stephanie S. Liu Hong Kong

Denise Martinez-Zapien France

Elżbieta Poręba Poland

James C. Cooke United Kingdom

Sarmistha Bandyopadhyay United States

Barbara Walch‐Rückheim Germany

Kavi P.M. Mehta United States

Claire D. James

367 ×1.2

EPIDE

302 ×1.1

ONCOL

571 ×2.1

116 ×0.8

GENET

145 ×1.1

IMMUN

Citations per year, relative to Claire D. James Claire D. James (= 1×) peers Kavi P.M. Mehta

Countries citing papers authored by Claire D. James

Since Specialization

Citations

This map shows the geographic impact of Claire D. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire D. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire D. James more than expected).

Fields of papers citing papers by Claire D. James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire D. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire D. James. The network helps show where Claire D. James may publish in the future.

Co-authorship network of co-authors of Claire D. James

This figure shows the co-authorship network connecting the top 25 collaborators of Claire D. James. A scholar is included among the top collaborators of Claire D. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire D. James. Claire D. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

James, Claire D., Rachel L. Lewis, Molly L. Bristol, et al.. (2024). Human papillomavirus 16 replication converts SAMHD1 into a homologous recombination factor and promotes its recruitment to replicating viral DNA. Journal of Virology. 98(9). e0082624–e0082624. 1 indexed citations

Patterson, Molly R., James A. Scarth, Christopher W. Wasson, et al.. (2024). E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer. Oncogene. 43(28). 2184–2198. 3 indexed citations

James, Claire D., et al.. (2024). HPV16 genome structure analysis in oropharyngeal cancer PDXs identifies tumors with integrated and episomal genomes. SHILAP Revista de lepidopterología. 18. 200285–200285. 4 indexed citations

James, Claire D., et al.. (2024). Fibroblasts regulate the transcriptional signature of human papillomavirus-positive keratinocytes. SHILAP Revista de lepidopterología. 19. 200302–200302. 1 indexed citations

James, Claire D., et al.. (2024). Fibroblast stromal support model for predicting human papillomavirus-associated cancer drug responses. Journal of Virology. 98(10). e0102424–e0102424. 1 indexed citations

Khalil, M. I., et al.. (2024). The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer. Journal of Virology. 98(2). e0172623–e0172623. 6 indexed citations

James, Claire D., Xu Wang, Molly L. Bristol, et al.. (2023). Direct interaction with the BRD4 carboxyl-terminal motif (CTM) and TopBP1 is required for human papillomavirus 16 E2 association with mitotic chromatin and plasmid segregation function. Journal of Virology. 97(10). e0078223–e0078223. 6 indexed citations

Khalil, M. I., Craig Welbon, Claire D. James, et al.. (2023). HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer. PLoS Pathogens. 19(3). e1011171–e1011171. 15 indexed citations

James, Claire D., et al.. (2023). Human Papillomavirus 16 E2 Interaction with TopBP1 Is Required for E2 and Viral Genome Stability during the Viral Life Cycle. Journal of Virology. 97(3). e0006323–e0006323. 17 indexed citations

10.

Wang, Xu, et al.. (2022). Human papillomavirus 16 E2 blocks cellular senescence in response to activation of the DNA damage response. Virology. 575. 54–62. 5 indexed citations

11.

James, Claire D., Fatmata Sesay, Audra N. Iness, et al.. (2021). Restoring the DREAM Complex Inhibits the Proliferation of High-Risk HPV Positive Human Cells. Cancers. 13(3). 489–489. 12 indexed citations

12.

James, Claire D., Dipon Das, M.W. Day, et al.. (2021). CK2 Phosphorylation of Human Papillomavirus 16 E2 on Serine 23 Promotes Interaction with TopBP1 and Is Critical for E2 Interaction with Mitotic Chromatin and the Viral Life Cycle. mBio. 12(5). e0116321–e0116321. 24 indexed citations

13.

Facompre, Nicole D., Pavithra Rajagopalan, Varun Sahu, et al.. (2020). Identifying predictors of HPV ‐related head and neck squamous cell carcinoma progression and survival through patient‐derived models. International Journal of Cancer. 147(11). 3236–3249. 35 indexed citations

14.

James, Claire D., et al.. (2020). Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription. mSphere. 5(1). 37 indexed citations

15.

Das, Dipon, Molly L. Bristol, Claire D. James, et al.. (2019). Werner Helicase Control of Human Papillomavirus 16 E1-E2 DNA Replication Is Regulated by SIRT1 Deacetylation. mBio. 10(2). 34 indexed citations

16.

Evans, Michael R., Claire D. James, Öonagh Loughran, et al.. (2017). A keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer. Oncotarget. 8(47). 81892–81909. 28 indexed citations

17.

Delury, Craig, Elizabeth K. Marsh, Claire D. James, et al.. (2013). The Role of Protein Kinase A Regulation of the E6 PDZ-Binding Domain during the Differentiation-Dependent Life Cycle of Human Papillomavirus Type 18. Journal of Virology. 87(17). 9463–9472. 53 indexed citations

18.

Yacoub, Adly, Clint Mitchell, Young Ki Hong, et al.. (2004). MDA-7 regulates cell growth and radiosensitivity in vitro of primary (Non-Established) human glioma cells. Cancer Biology & Therapy. 3(8). 739–751. 70 indexed citations

19.

Koch, Kevin M., Brian Corrigan, Claire D. James, et al.. (2004). Alosetron repeat dose pharmacokinetics, effects on enzyme activities, and influence of demographic factors. Alimentary Pharmacology & Therapeutics. 20(2). 223–230. 22 indexed citations

20.

Frederick, Lori, et al.. (2000). Diversity and frequency of EGFR mutations in human glioblastomas. 41. 357. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact